BUDGET IMPACT OF AN EXTENDED HALF LIFE RECOMBINANT FVIII THERAPY FOR A HYPOTHETICAL POPULATION OF SEVERE HEMOPHILIA A PATIENTS IN AN INSURED POPULATION IN THE UNITED STATES
Abstract
Authors
M. Bron Y. Xiong J. Booth P.H. Glover J. Epstein